Patents Assigned to Ablation Technologies Inc.
-
Patent number: 11839459Abstract: A system for determining cardiac targets is provided. The system may include at least one processing device configured to carry out instructions to receive cardiac imaging data, segment the cardiac imaging data to identify at least two types of cardiac tissue, generate a cardiac model based on the identified tissue, simulate cardiac activity based on the generated cardiac model, and identify at least one cardiac target based on the simulation. A cardiac therapy system may be utilized to provide feedback to a user in order to guide a cardiac treatment device to a cardiac target.Type: GrantFiled: February 22, 2021Date of Patent: December 12, 2023Assignee: CardioSolv Ablation Technologies, Inc.Inventors: Robert Blake, Scott Kokones, Brock Tice
-
Publication number: 20230177688Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient’s heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: ApplicationFiled: December 14, 2022Publication date: June 8, 2023Applicant: CARDIOSOLV ABLATION TECHNOLOGIES, INC.Inventor: Robert Clayton BLAKE, III
-
Patent number: 11532078Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient's heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: GrantFiled: May 12, 2020Date of Patent: December 20, 2022Assignee: CardioSolv Ablation Technologies, Inc.Inventor: Robert Clayton Blake, III
-
Patent number: 10925511Abstract: A system for determining cardiac targets is provided. The system may include at least one processing device configured to carry out instructions to receive cardiac imaging data, segment the cardiac imaging data to identify at least two types of cardiac tissue, generate a cardiac model based on the identified tissue, simulate cardiac activity based on the generated cardiac model, and identify at least one cardiac target based on the simulation. A cardiac therapy system may be utilized to provide feedback to a user in order to guide a cardiac treatment device to a cardiac target.Type: GrantFiled: July 24, 2015Date of Patent: February 23, 2021Assignee: CardioSolv Ablation Technologies, Inc.Inventors: Robert Blake, Scott Kokones, Brock Tice
-
Publication number: 20200273170Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient's heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: ApplicationFiled: May 12, 2020Publication date: August 27, 2020Applicant: Cardiosolv Ablation Technologies, Inc.Inventor: Robert Clayton Blake, III
-
Patent number: 10679348Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient's heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: GrantFiled: August 23, 2019Date of Patent: June 9, 2020Assignee: CardioSolv Ablation Technologies, Inc.Inventor: Robert Clayton Blake, III
-
Publication number: 20190378272Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient's heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: ApplicationFiled: August 23, 2019Publication date: December 12, 2019Applicant: CARDIOSOLV ABLATION TECHNOLOGIES, INC.Inventor: Robert Clayton Blake III
-
Patent number: 10402966Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient's heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: GrantFiled: December 3, 2016Date of Patent: September 3, 2019Assignee: CardioSolv Ablation Technologies, Inc.Inventor: Robert Clayton Blake, III
-
Publication number: 20170161896Abstract: Methods and systems for identifying optimized ablation targets for treating and preventing arrhythmias sustained by reentrant circuits are described. The methods comprise receiving at least one mesh generated from one or more images of a patient's heart, receiving activation data generated from one or more simulations of electrical-signal propagation over the at least one mesh, generating at least one flow graph based on the activation data and the at least one mesh, and applying a max-flow min-cut algorithm to the at least one flow graph to determine at least one of a number, one or more dimensions, and one or more locations of one or more ablation targets. Non-transitory computer-readable media storing a set of instructions for treating and preventing arrhythmias sustained by reentrant circuits are also described.Type: ApplicationFiled: December 3, 2016Publication date: June 8, 2017Applicant: CARDIOSOLV ABLATION TECHNOLOGIES, INC.Inventor: Robert Clayton Blake, III
-
Patent number: 6579380Abstract: A method of removing graphite from metal molds used in the glass fabrication industry, the method including placing a metal glass-fabricating mold with graphite bonded thereto in a chamber, providing an oxygen rich mixture of combustible gases in the chamber, said oxygen rich mixture containing from about 10 to about 25% stoichiometric excess of oxygen, and igniting the oxygen rich mixture of combustible gases in the chamber to produce a temperature of at least about 6,000° F. and a pressure wave. A high temperature wave front and the pressure wave thereby produced remove graphite from the metal mold by ablation of the graphite.Type: GrantFiled: February 12, 2001Date of Patent: June 17, 2003Assignee: Ablation Technologies Inc.Inventors: Terry W. Martin, Alex Maule
-
Patent number: 6074337Abstract: An implantable seed for simultaneous delivery of thermal and radioactive radiation to target tissue comprises a tube or rod of a ferromagnetic alloy which, when subjected to an oscillating magnetic field will heat up, the alloy also being coated or otherwise treated with a radioactive isotope which gives off X-ray radiation during the decay thereof.Type: GrantFiled: November 16, 1998Date of Patent: June 13, 2000Assignee: Ablation Technologies, Inc.Inventors: Robert D. Tucker, Joseph A. Paulus
-
Patent number: 6007474Abstract: An instrument for implanting radioactive and/or thermal seeds in body tissue for radiation and/or heat therapy comprises a tubular hypodermic needle barrel affixed to a pistol-grip shaped handle incorporates a reciprocally movable push rod for stripping one such seed from a cartridge containing a plurality of seeds and advancing it to the end of the barrel. Actuation of a trigger in the pistol grip handle causes the barrel to retract relative to the push rod, causing the seed to be deposited in the channel in the body tissue created by the original puncturing thereof by the instrument's barrel.Type: GrantFiled: October 20, 1997Date of Patent: December 28, 1999Assignee: Ablation Technologies, Inc.Inventor: Mark A. Rydell
-
Patent number: 5976067Abstract: An implantable seed for simultaneous delivery of thermal and radioactive radiation to target tissue comprises a tube or rod of a ferromagnetic alloy which, when subjected to an oscillating magnetic field will heat up, the alloy also being coated or otherwise treated with a radioactive isotope which gives off X-ray radiation during the decay thereof.Type: GrantFiled: May 28, 1997Date of Patent: November 2, 1999Assignee: Ablation Technologies, Inc.Inventors: Robert D. Tucker, Joseph A. Paulus